C
C. G. M. Kallenberg
Researcher at University of Groningen
Publications - 105
Citations - 7153
C. G. M. Kallenberg is an academic researcher from University of Groningen. The author has contributed to research in topics: Lupus erythematosus & Anti-neutrophil cytoplasmic antibody. The author has an hindex of 40, co-authored 105 publications receiving 6803 citations.
Papers
More filters
Journal ArticleDOI
EULAR recommendations for the management of large vessel vasculitis
Chetan Mukhtyar,Loïc Guillevin,Maria C. Cid,Bhaskar Dasgupta,K de Groot,Wolfgang L. Gross,Thomas H. Hauser,Bernhard Hellmich,David Jayne,C. G. M. Kallenberg,Peter A. Merkel,Heiner Raspe,Carlo Salvarani,Dgi Scott,Coen A. Stegeman,Richard A. Watts,Kerstin Westman,James Witter,Halil Yazici,Raashid Luqmani +19 more
TL;DR: Recommendations for large vessel vasculitis have been formulated on the basis of evidence and expert consensus and are commended for use in everyday clinical practice.
Journal ArticleDOI
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
George Bertsias,John P. A. Ioannidis,Martin Aringer,Edward L.E.M. Bollen,Stefano Bombardieri,Ian N. Bruce,Ricard Cervera,Marinos C. Dalakas,Andrea Doria,John G. Hanly,Twj Huizinga,David A. Isenberg,C. G. M. Kallenberg,J.C. Piette,Matthias Schneider,N Scolding,Josef S Smolen,A Stara,Ioannis Tassiulas,Maria G Tektonidou,Angela Tincani,M.A. van Buchem,R. van Vollenhoven,M. M. Ward,Caroline Gordon,Dimitrios T. Boumpas +25 more
TL;DR: Neuropsychiatric manifestations in SLE patients should be first evaluated and treated as in patients without SLE, and secondarily attributed to SLE and treated accordingly.
Journal ArticleDOI
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
TL;DR: Serial assessment of anti-dsDNA antibody levels, especially by the Farr assay, is a sensitive and reasonably specific method for predicting disease exacerbations in SLE.
Journal ArticleDOI
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre
J. W. Cohen-Tervaert,M. G. Huitema,Ronald J. Hené,W.J. Sluiter,G. K. van der Hem,C. G. M. Kallenberg +5 more
TL;DR: Patients with biopsy-proven Wegener's granulomatosis were prospectively screened for clinical evidence of the disease 3-monthly, with antineutrophil cytoplasmic antibody measurements every month, and ANCA rose over 24 months.
Journal ArticleDOI
Prevention of relapses in systemic lupus erythematosus.
H. Bootsma,P. Spronk,G. de Boer,Pieter Limburg,C. G. M. Kallenberg,R. H. W. M. Derksen,J. Wolters-Dicke,F H Gmelig-Meyling,L. Kater,Jo Hermans +9 more
TL;DR: Treatment with prednisone as soon as a significant rise in anti-dsDNA occurs prevents relapse in most cases, without increasing the cumulative dose of prednisdone given.